• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I 型和 II 型上皮性卵巢癌的临床和超声特征。

Clinical and ultrasound features of type I and type II epithelial ovarian cancer.

机构信息

Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain.

出版信息

Int J Gynecol Cancer. 2013 May;23(4):680-4. doi: 10.1097/IGC.0b013e31828bdbb6.

DOI:10.1097/IGC.0b013e31828bdbb6
PMID:23502452
Abstract

OBJECTIVE

The objective of this study was to assess whether there are differences on ultrasound features between epithelial ovarian cancer (EOC) type I and type II.

METHODS

This was a retrospective study comprising 244 women (mean age, 55.2 years old) with histologically proven EOC treated at our institution over a 12-year period. Clinical (patient age and symptoms and tumor stage), ultrasound (tumor volume, tumor appearance on gray-scale ultrasound, and color score), and histopathologic records were reviewed. Tumors were classified as EOC type I or type II. Type I tumors comprise low-grade serous, low-grade endometrioid, clear cell, mucinous, and transitional cell carcinomas, whereas type II tumors comprise high-grade serous, high-grade endometrioid, malignant mixed mesodermal tumors, and undifferentiated carcinomas. Categorical variables were compared using χ(2) test. Continuous variables were compared using 1-way analysis of variance with Bonferroni post hoc test or Mann-Whitney U or Kruskal-Wallis test, depending on data distribution.

RESULTS

Sixty-seven women (27.5%) had type I EOC, and 177 (72.3%) had type II EOC. We observed that women with type I EOC were younger, presented asymptomatic at diagnosis more frequently, and had lower CA-125 levels and lower tumor stage than women with type II EOC. Type II EOCs were more frequently identified as a solid mass and were smaller lesions than type I EOC.

CONCLUSIONS

Some differences exist between type I and type II EOC in clinical and ultrasound manifestations. Although the clinical significance of these findings is still to be determined, this information could provide some clues to clinicians faced with the diagnosis of ovarian cancer.

摘要

目的

本研究旨在评估上皮性卵巢癌(EOC)Ⅰ型和Ⅱ型在超声特征上是否存在差异。

方法

这是一项回顾性研究,纳入了在我院接受治疗的 244 名组织学证实为 EOC 的女性患者(平均年龄 55.2 岁),研究时间为 12 年。回顾了临床(患者年龄、症状和肿瘤分期)、超声(肿瘤体积、灰阶超声上的肿瘤外观和彩色评分)和组织病理学记录。肿瘤分为 EOC Ⅰ型或Ⅱ型。Ⅰ型肿瘤包括低级别浆液性、低级别子宫内膜样、透明细胞、黏液性和移行细胞癌,而Ⅱ型肿瘤包括高级别浆液性、高级别子宫内膜样、恶性混合性中胚叶肿瘤和未分化癌。采用卡方检验比较分类变量,采用单因素方差分析(Bonferroni 事后检验)或 Mann-Whitney U 检验或 Kruskal-Wallis 检验比较连续变量,具体取决于数据分布。

结果

67 名女性(27.5%)为Ⅰ型 EOC,177 名女性(72.3%)为Ⅱ型 EOC。我们观察到,Ⅰ型 EOC 患者更年轻,诊断时无症状更为常见,CA-125 水平更低,肿瘤分期更低。Ⅱ型 EOC 更常被识别为实性肿块,且肿瘤体积小于Ⅰ型 EOC。

结论

Ⅰ型和Ⅱ型 EOC 在临床和超声表现上存在一些差异。尽管这些发现的临床意义仍有待确定,但这些信息可能为面临卵巢癌诊断的临床医生提供一些线索。

相似文献

1
Clinical and ultrasound features of type I and type II epithelial ovarian cancer.I 型和 II 型上皮性卵巢癌的临床和超声特征。
Int J Gynecol Cancer. 2013 May;23(4):680-4. doi: 10.1097/IGC.0b013e31828bdbb6.
2
CT and MRI findings of type I and type II epithelial ovarian cancer.I型和II型上皮性卵巢癌的CT和MRI表现。
Eur J Radiol. 2017 May;90:225-233. doi: 10.1016/j.ejrad.2017.02.017. Epub 2017 Mar 11.
3
Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis.评价Ⅰ型和Ⅱ型上皮性卵巢癌患者体外化疗反应谱:一项观察性研究的辅助分析。
Gynecol Oncol. 2015 Aug;138(2):267-71. doi: 10.1016/j.ygyno.2015.05.038. Epub 2015 May 30.
4
Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.超声标志物和术前 CA-125 用于区分交界性卵巢肿瘤和Ⅰ期卵巢癌。
Acta Obstet Gynecol Scand. 2013 Mar;92(3):285-92. doi: 10.1111/aogs.12046. Epub 2012 Dec 21.
5
[Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].[卵巢交界性肿瘤与Ⅰ期上皮性卵巢癌的临床特征:143例分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Feb 18;43(1):123-8.
6
Discrepant clinicopathologic characteristics and HE4 performance in type I and type II epithelial ovarian cancer.I型和II型上皮性卵巢癌的临床病理特征及HE4表现的差异
Int J Clin Exp Med. 2015 Nov 15;8(11):21303-10. eCollection 2015.
7
Ultrasound characteristics of early-stage high-grade serous ovarian cancer.早期高级别浆液性卵巢癌的超声特征。
Am J Obstet Gynecol. 2021 Oct;225(4):409.e1-409.e8. doi: 10.1016/j.ajog.2021.04.262. Epub 2021 May 13.
8
Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS).超声检测到卵巢肿块的无症状妇女患上皮性卵巢癌的风险:英国卵巢癌筛查协作试验(UKCTOCS)中的一项前瞻性队列研究。
Ultrasound Obstet Gynecol. 2012 Sep;40(3):338-44. doi: 10.1002/uog.12270.
9
TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.TP53 突变在所有上皮性卵巢癌亚型中都很常见,并且与黏液型中的 KRAS 突变同时发生。
Exp Mol Pathol. 2013 Oct;95(2):235-41. doi: 10.1016/j.yexmp.2013.08.004. Epub 2013 Aug 18.
10
Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.最初诊断为卵巢子宫内膜样癌的肿瘤的形态学和免疫组化重新评估,重点关注高级别肿瘤。
Am J Surg Pathol. 2016 Mar;40(3):302-12. doi: 10.1097/PAS.0000000000000550.

引用本文的文献

1
Contrast-enhanced ultrasound findings of ovarian Sertoli-Leydig cell tumor: a case report with ultrasonographic-pathological insights.卵巢支持-间质细胞瘤的超声造影表现:一例具有超声-病理见解的病例报告
BMC Womens Health. 2025 Jul 18;25(1):358. doi: 10.1186/s12905-025-03910-0.
2
A clinicoradiological model based on clinical and CT features for preoperative prediction of histological classification in patients with epithelial ovarian cancers: a two-center study.基于临床和CT特征的上皮性卵巢癌患者组织学分类术前预测的临床放射学模型:一项双中心研究
Abdom Radiol (NY). 2025 Feb 21. doi: 10.1007/s00261-025-04842-x.
3
Feasibility of iodine concentration parameter and extracellular volume fraction derived from dual-energy CT for distinguishing type I and type II epithelial ovarian carcinoma.
基于双能CT的碘浓度参数和细胞外体积分数鉴别Ⅰ型和Ⅱ型上皮性卵巢癌的可行性
Abdom Radiol (NY). 2024 Dec 12. doi: 10.1007/s00261-024-04752-4.
4
A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?一项双中心研究:超声放射组学能否区分 CA125 水平正常的Ⅰ型和Ⅱ型上皮性卵巢癌患者?
Br J Radiol. 2024 Oct 1;97(1162):1706-1712. doi: 10.1093/bjr/tqae144.
5
Tumor Markers and Their Diagnostic Significance in Ovarian Cancer.肿瘤标志物及其在卵巢癌中的诊断意义
Life (Basel). 2023 Aug 5;13(8):1689. doi: 10.3390/life13081689.
6
Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer.环状 RNA N4BP2L2 在 I 型和 II 型上皮性卵巢癌中的诊断价值。
BMC Cancer. 2022 Nov 24;22(1):1210. doi: 10.1186/s12885-022-10138-w.
7
Nomogram based on ultrasound radiomics score and clinical variables for predicting histologic subtypes of epithelial ovarian cancer.基于超声放射组学评分和临床变量的列线图预测上皮性卵巢癌的组织学亚型。
Br J Radiol. 2022 Aug 1;95(1136):20211332. doi: 10.1259/bjr.20211332. Epub 2022 Jun 9.
8
CA125 and Ovarian Cancer: A Comprehensive Review.CA125与卵巢癌:一篇综述
Cancers (Basel). 2020 Dec 11;12(12):3730. doi: 10.3390/cancers12123730.
9
Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma.卵巢癌患者中K-RAS突变和CA125肿瘤标志物的患病率。
Caspian J Intern Med. 2020 Winter;11(1):75-82. doi: 10.22088/cjim.11.1.75.
10
Magnetic resonance imaging in categorization of ovarian epithelial cancer and survival analysis with focus on apparent diffusion coefficient value: correlation with Ki-67 expression and serum cancer antigen-125 level.磁共振成像在卵巢上皮性癌的分类及生存分析中的应用,重点关注表观扩散系数值:与 Ki-67 表达和血清癌抗原 125 水平的相关性。
J Ovarian Res. 2019 Jun 26;12(1):59. doi: 10.1186/s13048-019-0534-0.